Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Kidney Failure, Chronic | 18 | 2023 | 2534 | 3.480 |
Why?
|
Renal Insufficiency, Chronic | 20 | 2023 | 2200 | 2.990 |
Why?
|
Serum Albumin | 9 | 2023 | 675 | 2.760 |
Why?
|
Renal Dialysis | 17 | 2024 | 1783 | 2.410 |
Why?
|
Protein Processing, Post-Translational | 6 | 2022 | 1986 | 1.730 |
Why?
|
Uremia | 6 | 2022 | 200 | 1.680 |
Why?
|
Dialysis Solutions | 2 | 2022 | 38 | 1.480 |
Why?
|
Carbamates | 3 | 2015 | 196 | 1.300 |
Why?
|
Anemia | 4 | 2023 | 1502 | 1.210 |
Why?
|
Sickle Cell Trait | 3 | 2021 | 81 | 1.040 |
Why?
|
Glomerular Filtration Rate | 8 | 2023 | 2167 | 0.980 |
Why?
|
Acute Kidney Injury | 7 | 2021 | 1968 | 0.970 |
Why?
|
Anemia, Sickle Cell | 3 | 2021 | 1020 | 0.930 |
Why?
|
Metabolome | 4 | 2018 | 894 | 0.900 |
Why?
|
Metabolomics | 3 | 2017 | 1487 | 0.700 |
Why?
|
Diabetes Mellitus | 3 | 2023 | 5752 | 0.620 |
Why?
|
Peritoneal Dialysis | 1 | 2018 | 147 | 0.580 |
Why?
|
Cardiovascular Diseases | 5 | 2022 | 15142 | 0.530 |
Why?
|
Kidney Diseases | 2 | 2024 | 2146 | 0.480 |
Why?
|
Amino Acids | 3 | 2018 | 1733 | 0.450 |
Why?
|
Erythropoietin | 2 | 2016 | 726 | 0.430 |
Why?
|
Carnitine | 1 | 2013 | 245 | 0.430 |
Why?
|
Diabetic Nephropathies | 2 | 2016 | 984 | 0.420 |
Why?
|
Kidney | 6 | 2022 | 7185 | 0.400 |
Why?
|
Diabetes Complications | 1 | 2018 | 1360 | 0.370 |
Why?
|
Hematinics | 1 | 2013 | 280 | 0.370 |
Why?
|
Parenteral Nutrition | 1 | 2015 | 650 | 0.370 |
Why?
|
Glomerulonephritis, IGA | 2 | 2021 | 67 | 0.370 |
Why?
|
Kidney Cortex Necrosis | 1 | 2008 | 6 | 0.340 |
Why?
|
Blood Glucose | 1 | 2023 | 6259 | 0.330 |
Why?
|
Hyponatremia | 2 | 2023 | 297 | 0.320 |
Why?
|
Quality of Life | 4 | 2024 | 12788 | 0.320 |
Why?
|
Drug Resistance | 1 | 2013 | 1606 | 0.300 |
Why?
|
Olfaction Disorders | 2 | 2022 | 222 | 0.300 |
Why?
|
Hypertension, Pulmonary | 1 | 2018 | 1534 | 0.290 |
Why?
|
Methylamines | 2 | 2018 | 122 | 0.280 |
Why?
|
Analgesics, Opioid | 2 | 2023 | 3677 | 0.260 |
Why?
|
Humans | 55 | 2024 | 743811 | 0.260 |
Why?
|
Liver Cirrhosis | 3 | 2021 | 1859 | 0.250 |
Why?
|
Disease Progression | 5 | 2023 | 13273 | 0.230 |
Why?
|
Myelinolysis, Central Pontine | 1 | 2023 | 18 | 0.230 |
Why?
|
Pseudouridine | 1 | 2022 | 24 | 0.220 |
Why?
|
Charcoal | 1 | 2022 | 62 | 0.210 |
Why?
|
Cohort Studies | 8 | 2023 | 40545 | 0.210 |
Why?
|
Taste Disorders | 1 | 2022 | 41 | 0.200 |
Why?
|
Middle Aged | 23 | 2023 | 213241 | 0.200 |
Why?
|
Calciphylaxis | 1 | 2023 | 124 | 0.200 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2023 | 11729 | 0.190 |
Why?
|
Hand Strength | 1 | 2024 | 448 | 0.190 |
Why?
|
Prospective Studies | 12 | 2022 | 53250 | 0.190 |
Why?
|
Receptors, Purinergic P2Y | 1 | 2020 | 25 | 0.190 |
Why?
|
Hemoglobin, Sickle | 1 | 2019 | 122 | 0.170 |
Why?
|
Vitamin D | 3 | 2021 | 3222 | 0.170 |
Why?
|
Male | 26 | 2024 | 349776 | 0.160 |
Why?
|
Glycosylation | 1 | 2022 | 1129 | 0.160 |
Why?
|
Acetylcarnitine | 1 | 2018 | 9 | 0.160 |
Why?
|
Indican | 1 | 2018 | 17 | 0.160 |
Why?
|
Cresols | 1 | 2018 | 28 | 0.160 |
Why?
|
Sulfuric Acid Esters | 1 | 2018 | 33 | 0.160 |
Why?
|
Case-Control Studies | 6 | 2021 | 21733 | 0.160 |
Why?
|
Angiopoietin-2 | 1 | 2019 | 172 | 0.150 |
Why?
|
Mass Spectrometry | 2 | 2016 | 2203 | 0.150 |
Why?
|
Analytic Sample Preparation Methods | 1 | 2016 | 7 | 0.150 |
Why?
|
Kidney Transplantation | 3 | 2022 | 4251 | 0.140 |
Why?
|
Female | 23 | 2024 | 380020 | 0.140 |
Why?
|
Blood Urea Nitrogen | 1 | 2016 | 191 | 0.140 |
Why?
|
Aged | 14 | 2023 | 163178 | 0.140 |
Why?
|
Buprenorphine | 1 | 2023 | 640 | 0.130 |
Why?
|
Amino Acids, Branched-Chain | 1 | 2018 | 251 | 0.130 |
Why?
|
Antigens, Differentiation, Myelomonocytic | 1 | 2016 | 294 | 0.130 |
Why?
|
Arteries | 1 | 2019 | 1119 | 0.120 |
Why?
|
Tryptophan | 1 | 2016 | 478 | 0.120 |
Why?
|
Vitamin D Deficiency | 2 | 2015 | 1342 | 0.120 |
Why?
|
Ergocalciferols | 1 | 2015 | 110 | 0.120 |
Why?
|
Lectins | 1 | 2016 | 513 | 0.120 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1463 | 0.120 |
Why?
|
Myelodysplastic Syndromes | 1 | 2023 | 1352 | 0.110 |
Why?
|
Obesity | 1 | 2015 | 12744 | 0.110 |
Why?
|
Cause of Death | 3 | 2018 | 3580 | 0.100 |
Why?
|
Emotions | 1 | 2024 | 2656 | 0.100 |
Why?
|
Multivariate Analysis | 3 | 2016 | 12243 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
Hypertension | 4 | 2022 | 8480 | 0.100 |
Why?
|
Time Factors | 5 | 2018 | 40038 | 0.100 |
Why?
|
Hip Fractures | 1 | 2019 | 955 | 0.100 |
Why?
|
Odds Ratio | 2 | 2013 | 9848 | 0.100 |
Why?
|
Aged, 80 and over | 5 | 2019 | 57744 | 0.090 |
Why?
|
Picea | 1 | 2010 | 5 | 0.090 |
Why?
|
Chromatography, Liquid | 1 | 2013 | 975 | 0.090 |
Why?
|
Dietary Supplements | 3 | 2023 | 3292 | 0.090 |
Why?
|
Cholesterol | 2 | 2015 | 2922 | 0.090 |
Why?
|
Pruritus | 2 | 2023 | 361 | 0.080 |
Why?
|
Logistic Models | 2 | 2013 | 13404 | 0.080 |
Why?
|
Blood Pressure | 2 | 2015 | 8551 | 0.080 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2023 | 3524 | 0.080 |
Why?
|
Reproducibility of Results | 2 | 2023 | 19894 | 0.070 |
Why?
|
Hemoglobins | 1 | 2013 | 1531 | 0.070 |
Why?
|
Risk Assessment | 2 | 2021 | 23327 | 0.070 |
Why?
|
Chi-Square Distribution | 1 | 2013 | 3503 | 0.070 |
Why?
|
Adult | 9 | 2023 | 213889 | 0.070 |
Why?
|
Molecular Targeted Therapy | 1 | 2018 | 2727 | 0.070 |
Why?
|
Risk Factors | 7 | 2023 | 72252 | 0.070 |
Why?
|
Proteins | 1 | 2022 | 6098 | 0.070 |
Why?
|
Magnetic Resonance Spectroscopy | 1 | 2016 | 3758 | 0.070 |
Why?
|
Pilot Projects | 2 | 2019 | 8316 | 0.070 |
Why?
|
Glucose | 1 | 2018 | 4398 | 0.070 |
Why?
|
Animals | 5 | 2020 | 168660 | 0.060 |
Why?
|
Mitochondria | 1 | 2016 | 3513 | 0.060 |
Why?
|
Diet, Protein-Restricted | 1 | 2023 | 71 | 0.060 |
Why?
|
Linear Models | 1 | 2013 | 5952 | 0.060 |
Why?
|
Morbidity | 1 | 2008 | 1768 | 0.060 |
Why?
|
United States | 4 | 2021 | 69859 | 0.050 |
Why?
|
Creatinine | 2 | 2020 | 1918 | 0.050 |
Why?
|
Treatment Outcome | 4 | 2018 | 63042 | 0.050 |
Why?
|
HIV Infections | 1 | 2008 | 16715 | 0.050 |
Why?
|
Cross-Sectional Studies | 3 | 2022 | 25032 | 0.050 |
Why?
|
Azacitidine | 1 | 2023 | 347 | 0.050 |
Why?
|
Longitudinal Studies | 1 | 2018 | 13980 | 0.050 |
Why?
|
Kidney Tubular Necrosis, Acute | 1 | 2021 | 66 | 0.050 |
Why?
|
Paresthesia | 1 | 2022 | 160 | 0.050 |
Why?
|
Histamine | 1 | 2022 | 507 | 0.050 |
Why?
|
Hepatorenal Syndrome | 1 | 2021 | 61 | 0.050 |
Why?
|
Biological Availability | 1 | 2021 | 397 | 0.050 |
Why?
|
Retrospective Studies | 4 | 2023 | 77410 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15067 | 0.050 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2015 | 3255 | 0.040 |
Why?
|
Survival Analysis | 2 | 2023 | 10251 | 0.040 |
Why?
|
Survival Rate | 2 | 2015 | 12786 | 0.040 |
Why?
|
Hematuria | 1 | 2020 | 235 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1676 | 0.040 |
Why?
|
Gait | 1 | 2024 | 795 | 0.040 |
Why?
|
Sodium | 1 | 2023 | 1622 | 0.040 |
Why?
|
Glomerulonephritis | 1 | 2020 | 372 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2020 | 390 | 0.040 |
Why?
|
Body Mass Index | 1 | 2015 | 12718 | 0.040 |
Why?
|
Theophylline | 1 | 2017 | 132 | 0.040 |
Why?
|
Cytoskeleton | 1 | 2022 | 1185 | 0.040 |
Why?
|
Walking | 1 | 2024 | 1182 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2017 | 211 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2022 | 878 | 0.030 |
Why?
|
Chemokines | 1 | 2020 | 968 | 0.030 |
Why?
|
Metagenomics | 1 | 2019 | 428 | 0.030 |
Why?
|
RNA, Ribosomal, 16S | 1 | 2019 | 954 | 0.030 |
Why?
|
Diagnosis, Differential | 2 | 2021 | 12954 | 0.030 |
Why?
|
Liver Failure, Acute | 1 | 2016 | 165 | 0.030 |
Why?
|
Bayes Theorem | 1 | 2023 | 2307 | 0.030 |
Why?
|
Fatigue | 1 | 2022 | 1530 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2019 | 866 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2020 | 805 | 0.030 |
Why?
|
Urea | 1 | 2016 | 450 | 0.030 |
Why?
|
Disease-Free Survival | 1 | 2023 | 6895 | 0.030 |
Why?
|
End Stage Liver Disease | 1 | 2016 | 314 | 0.030 |
Why?
|
New England | 1 | 2015 | 1022 | 0.030 |
Why?
|
RNA | 1 | 2022 | 2748 | 0.030 |
Why?
|
Heart Failure | 1 | 2015 | 10896 | 0.020 |
Why?
|
Monocytes | 1 | 2020 | 2593 | 0.020 |
Why?
|
Arctic Regions | 1 | 2010 | 25 | 0.020 |
Why?
|
Fertilizers | 1 | 2010 | 24 | 0.020 |
Why?
|
Troponin T | 1 | 2015 | 754 | 0.020 |
Why?
|
Echocardiography | 1 | 2022 | 5096 | 0.020 |
Why?
|
Soil | 1 | 2010 | 106 | 0.020 |
Why?
|
Freezing | 1 | 2010 | 303 | 0.020 |
Why?
|
Plant Diseases | 1 | 2010 | 150 | 0.020 |
Why?
|
Prognosis | 2 | 2021 | 29052 | 0.020 |
Why?
|
Renin-Angiotensin System | 1 | 2013 | 758 | 0.020 |
Why?
|
Biopsy | 1 | 2020 | 6750 | 0.020 |
Why?
|
Neutrophils | 1 | 2020 | 3718 | 0.020 |
Why?
|
Liver Transplantation | 1 | 2019 | 2119 | 0.020 |
Why?
|
Administration, Oral | 1 | 2015 | 3912 | 0.020 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2023 | 9944 | 0.020 |
Why?
|
Ultrasonography | 1 | 2020 | 5986 | 0.020 |
Why?
|
Pain | 1 | 2022 | 4987 | 0.020 |
Why?
|
Natriuretic Peptide, Brain | 1 | 2015 | 1572 | 0.020 |
Why?
|
Death, Sudden, Cardiac | 1 | 2015 | 1542 | 0.020 |
Why?
|
Nutritional Status | 1 | 2015 | 1608 | 0.020 |
Why?
|
Hospitalization | 2 | 2016 | 10259 | 0.020 |
Why?
|
Massachusetts | 1 | 2019 | 8660 | 0.020 |
Why?
|
Ecosystem | 1 | 2010 | 473 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2020 | 14563 | 0.020 |
Why?
|
Prevalence | 1 | 2022 | 15211 | 0.020 |
Why?
|
Incidence | 1 | 2023 | 20948 | 0.020 |
Why?
|
Vitamins | 1 | 2013 | 1622 | 0.020 |
Why?
|
Climate Change | 1 | 2010 | 418 | 0.020 |
Why?
|
Chronic Disease | 1 | 2019 | 9139 | 0.020 |
Why?
|
Models, Theoretical | 1 | 2016 | 3587 | 0.010 |
Why?
|
Environment | 1 | 2010 | 1121 | 0.010 |
Why?
|
Water | 1 | 2010 | 1394 | 0.010 |
Why?
|
Sepsis | 1 | 2016 | 2593 | 0.010 |
Why?
|
Peptide Fragments | 1 | 2015 | 5096 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12354 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2015 | 12020 | 0.010 |
Why?
|
Comorbidity | 1 | 2015 | 10380 | 0.010 |
Why?
|
Severity of Illness Index | 1 | 2016 | 15526 | 0.010 |
Why?
|
Atrial Fibrillation | 1 | 2015 | 5033 | 0.010 |
Why?
|
Mice | 1 | 2020 | 81154 | 0.010 |
Why?
|
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(40)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_